Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 92.04%255.66M | 55.36%794.68M | 45.12%566.38M | 45.04%308.71M | 63.32%133.13M | 10.64%511.5M | 10.23%390.28M | 19.49%212.84M | 0.92%81.51M | 8.67%462.29M |
Operating revenue | 92.04%255.66M | 55.36%794.68M | 45.12%566.38M | 45.04%308.71M | 63.32%133.13M | 10.64%511.5M | 10.23%390.28M | 19.49%212.84M | 0.92%81.51M | 8.67%462.29M |
Total operating cost | 69.02%158.73M | 56.14%493.45M | 51.54%354.62M | 47.62%203.1M | 64.16%93.91M | 16.42%316.03M | 14.02%234.01M | 21.15%137.58M | 4.72%57.21M | 6.98%271.46M |
Operating cost | 95.35%121.17M | 65.47%348.02M | 56.99%245.6M | 49.86%135.96M | 77.82%62.03M | 14.31%210.32M | 14.74%156.45M | 28.87%90.73M | 7.33%34.88M | 11.67%183.99M |
Operating tax surcharges | 159.24%2.79M | 26.00%8.18M | 12.92%5.88M | -3.55%2.78M | -12.94%1.07M | -1.07%6.49M | 6.23%5.21M | 25.56%2.88M | 13.47%1.23M | 32.25%6.56M |
Operating expense | -8.11%8.67M | 31.28%38.25M | 30.68%29.09M | 40.80%19.26M | 46.86%9.43M | 22.44%29.14M | 9.90%22.26M | 2.55%13.68M | -11.88%6.42M | -3.05%23.8M |
Administration expense | 18.32%12.74M | 47.43%53.57M | 44.43%38.05M | 47.17%23.5M | 47.50%10.77M | 24.79%36.33M | 14.60%26.34M | 18.13%15.97M | 21.77%7.3M | -6.85%29.12M |
Financial expense | 126.59%245.4K | -58.04%-4.77M | 55.48%-1.19M | 2.19%-1.96M | -188.27%-922.8K | 29.39%-3.02M | 24.50%-2.68M | -13.82%-2M | -295.08%-320.11K | -89.07%-4.28M |
-Interest expense (Financial expense) | -52.63%4.21K | -70.39%177.43K | -48.76%195.56K | 42.23%188.08K | -15.40%8.88K | 1,081.45%599.27K | 871.49%381.63K | 423.27%132.24K | 10.62%10.49K | 1,074.14%50.72K |
-Interest Income (Financial expense) | 37.32%-556.91K | -9.91%-3.76M | -3.42%-2.49M | -43.53%-1.92M | -57.89%-888.56K | -73.16%-3.42M | -73.94%-2.41M | -52.08%-1.34M | -31.92%-562.78K | 23.42%-1.98M |
Research and development | 13.79%13.12M | 36.55%50.21M | 40.71%37.19M | 44.27%23.57M | 50.00%11.53M | 13.94%36.77M | 8.78%26.43M | 3.59%16.34M | -1.92%7.69M | 5.84%32.27M |
Credit Impairment Loss | -197.30%-267.75K | -288.00%-1.81M | -91.89%-2.66M | -319.97%-273.17K | -64.10%275.18K | -322.65%-466.59K | -46.81%-1.39M | -110.15%-65.04K | 9.19%766.62K | 139.55%209.57K |
Asset Impairment Loss | ---1.37M | -486.90%-5.52M | -2,530.29%-3.12M | ---- | ---- | 46.67%-939.76K | -14.08%-118.52K | -14.08%-118.52K | ---- | -811.90%-1.76M |
Other net revenue | ||||||||||
Invest income | -31.44%3.42M | -21.83%18.4M | -19.82%14.14M | -6.83%9.88M | -6.04%4.98M | 20.55%23.54M | 17.93%17.64M | 2.45%10.61M | 0.99%5.3M | -5.51%19.53M |
Asset deal income | ---1.96K | -179.08%-225.03K | -166.52%-189.31K | -169.46%-197.67K | ---- | 543.18%284.57K | 7,852.57%284.57K | --284.57K | --265.4K | 93.75%-64.21K |
Other revenue | -54.02%2.12M | 27.24%10.78M | 30.10%8.09M | 2.86%6.04M | 5.46%4.61M | 47.91%8.47M | 174.12%6.22M | 164.70%5.87M | 423.05%4.37M | -31.95%5.73M |
Operating profit | 105.42%100.83M | 42.63%322.85M | 27.46%228.02M | 31.81%121.06M | 40.20%49.08M | 5.54%226.36M | 8.44%178.9M | 18.24%91.84M | 6.32%35.01M | 7.79%214.47M |
Add:Non operating Income | -99.99%0.27 | 479.97%392.3K | 134.00%2.93K | 135.63%2.95K | 537.78%2.94K | -42.21%67.64K | -98.88%1.25K | -23.03%1.25K | -61.53%461.6 | -99.29%117.05K |
Less:Non operating expense | 38.25%407.26K | 832.26%1.44M | 821.10%847.93K | 268.20%295.89K | 785.57%294.58K | -85.92%154.21K | -75.99%92.06K | -72.88%80.36K | -87.02%33.26K | 133.23%1.1M |
Total profit | 105.82%100.42M | 42.22%321.81M | 27.05%227.17M | 31.60%120.76M | 39.50%48.79M | 5.98%226.27M | 8.56%178.81M | 18.59%91.76M | 7.05%34.98M | -0.75%213.49M |
Less:Income tax cost | 76.13%13.26M | 28.47%42.15M | 29.68%31.63M | 37.38%17.18M | 52.75%7.53M | 16.69%32.81M | 5.49%24.39M | 20.55%12.51M | 17.80%4.93M | -8.80%28.12M |
Net profit | 111.23%87.16M | 44.56%279.66M | 26.64%195.55M | 30.69%103.58M | 37.32%41.26M | 4.36%193.46M | 9.06%154.42M | 18.29%79.26M | 5.47%30.05M | 0.59%185.38M |
Net profit from continuing operation | 111.23%87.16M | 44.56%279.66M | 26.64%195.55M | 30.69%103.58M | 37.32%41.26M | 4.36%193.46M | 9.06%154.42M | 18.29%79.26M | 5.47%30.05M | 0.59%185.38M |
Net profit of parent company owners | 111.23%87.16M | 44.56%279.66M | 26.64%195.55M | 30.69%103.58M | 37.32%41.26M | 4.36%193.46M | 9.06%154.42M | 18.29%79.26M | 5.47%30.05M | 0.59%185.38M |
Earning per share | ||||||||||
Basic earning per share | 106.25%0.33 | 38.96%1.07 | 20.97%0.75 | 21.21%0.4 | 33.33%0.16 | 0.00%0.77 | 5.08%0.62 | 17.86%0.33 | 0.00%0.12 | 0.00%0.77 |
Diluted earning per share | 106.25%0.33 | 38.96%1.07 | 20.97%0.75 | 21.21%0.4 | 33.33%0.16 | 0.00%0.77 | 5.08%0.62 | 17.86%0.33 | 0.00%0.12 | 0.00%0.77 |
Other composite income | 76.38%-78.35K | -1,287.14%-1.04M | 202.85%1M | -1,060.79%-1.56M | -434.46%-331.76K | -79.80%87.39K | -6.99%331.77K | -5.21%161.96K | 4,469.07%99.19K | 485.40%432.67K |
Other composite income of parent company owners | 76.38%-78.35K | -1,287.14%-1.04M | 202.85%1M | -1,060.79%-1.56M | -434.46%-331.76K | -79.80%87.39K | -6.99%331.77K | -5.21%161.96K | 4,469.07%99.19K | 485.40%432.67K |
Total composite income | 112.75%87.09M | 43.96%278.62M | 27.01%196.55M | 28.47%102.03M | 35.77%40.93M | 4.16%193.55M | 9.02%154.75M | 18.23%79.42M | 5.83%30.15M | 0.89%185.81M |
Total composite income of parent company owners | 112.75%87.09M | 43.96%278.62M | 27.01%196.55M | 28.47%102.03M | 35.77%40.93M | 4.16%193.55M | 9.02%154.75M | 18.23%79.42M | 5.83%30.15M | 0.89%185.81M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | -- | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.